AUSTIN, Texas--(BUSINESS WIRE)--Astrotech Corporation (Nasdaq:ASTC), a leader in the commercialization of government sponsored advanced space technologies, today announced that Thomas B. Pickens III, CEO, and Eric Stober, CFO, will be participating in the 16th Annual B. Riley & Co. Investor Conference. Management will be hosting a formal presentation and webcast on Tuesday, May 12, 2015 at 9:30 am Pacific time in the Echo Park room at the Loews Hollywood Hotel in Los Angeles, California.
Management will provide an update on the Company’s business units and growth strategy and will be available for one-on-one meetings throughout the day.
Interested parties may access a live webcast of the Company’s presentation at the following web address: http://www.brileywebcast.com/viewwebcasts/profile.php?ticker=ASTC.
Astrotech Corporation is an Austin, TX based technology company that has evolved from over 30 years in the human spaceflight, Space Shuttle, and Department of Defense satellite programs. The company has become a leader in the commercialization of government sponsored advanced space technologies.
1st Detect Corporation has developed a mass spectrometer that was designed for use on the International Space Station, but also revolutionizes the chemical detection and analysis market by delivering laboratory performance mass spectrometry in a small, affordable, and portable package. 1st Detect's technology is useful in the semiconductor, food & beverage processing, laboratory, process control, explosive detection, and chemical warfare markets.
Astrogenetix Corporation is the result of over $4 Billion spent by NASA over a 25 year period on experiments conducted in sustained microgravity, where results were only achieved while orbiting in space. Astrotech designed and flew 1,113 of these experiments and after an extensive review, discovered that microgravity greatly enhanced the discovery of valuable vaccine and therapeutics. The company has completed 12 successful biomarker discovery missions to the International Space Station and has identified a salmonella vaccine candidate, while 10 additional discoveries are in the pipeline. NASA has awarded Astrogenetix 26 free flights to the $130 Billion ISS National Laboratory, along with full crew support.
Astral Images, Inc. was created to commercialize identified government funded satellite image correction technologies. Along with the acquisition of certain established defect correction technologies, first funded by IBM and Kodak, Astral is positioned to be the world leader in the technology required to convert and repair feature films and film based television series to the new digital HDR Ultra-High Definition 4K standards.